| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 30 | 2021 | 72 | 10.190 |
Why?
|
| Ethics, Medical | 42 | 2022 | 86 | 8.810 |
Why?
|
| Informed Consent | 28 | 2022 | 127 | 6.720 |
Why?
|
| Tissue and Organ Procurement | 19 | 2022 | 164 | 5.900 |
Why?
|
| Periodicals as Topic | 12 | 2021 | 158 | 4.970 |
Why?
|
| Cardiac Surgical Procedures | 27 | 2021 | 450 | 4.350 |
Why?
|
| Thoracic Surgical Procedures | 15 | 2021 | 37 | 4.310 |
Why?
|
| Tissue Donors | 15 | 2022 | 195 | 4.230 |
Why?
|
| Conflict of Interest | 18 | 2017 | 48 | 4.180 |
Why?
|
| Physician-Patient Relations | 20 | 2019 | 261 | 3.420 |
Why?
|
| Humans | 304 | 2022 | 68618 | 3.150 |
Why?
|
| Heart Transplantation | 10 | 2022 | 328 | 2.830 |
Why?
|
| Organ Transplantation | 9 | 2021 | 110 | 2.640 |
Why?
|
| Publishing | 10 | 2021 | 89 | 2.570 |
Why?
|
| Scientific Misconduct | 5 | 2020 | 12 | 2.550 |
Why?
|
| Surgeons | 9 | 2020 | 68 | 2.400 |
Why?
|
| Societies, Medical | 10 | 2020 | 403 | 2.390 |
Why?
|
| Heart Valve Prosthesis Implantation | 8 | 2018 | 164 | 2.330 |
Why?
|
| Truth Disclosure | 11 | 2019 | 48 | 2.320 |
Why?
|
| Physicians | 13 | 2014 | 324 | 2.300 |
Why?
|
| Brain Death | 6 | 2022 | 34 | 2.090 |
Why?
|
| Health Care Reform | 9 | 2012 | 62 | 2.080 |
Why?
|
| Biomedical Research | 11 | 2020 | 310 | 2.070 |
Why?
|
| Heart Valve Prosthesis | 17 | 2020 | 222 | 2.020 |
Why?
|
| Bioethical Issues | 6 | 2021 | 10 | 1.980 |
Why?
|
| Death | 8 | 2022 | 38 | 1.920 |
Why?
|
| United States | 62 | 2021 | 7367 | 1.890 |
Why?
|
| Confidentiality | 8 | 2022 | 62 | 1.880 |
Why?
|
| Morals | 9 | 2020 | 27 | 1.840 |
Why?
|
| Clinical Decision-Making | 4 | 2018 | 109 | 1.820 |
Why?
|
| General Surgery | 6 | 2020 | 95 | 1.810 |
Why?
|
| Public Policy | 9 | 2015 | 71 | 1.810 |
Why?
|
| Moral Obligations | 7 | 2019 | 9 | 1.760 |
Why?
|
| Delivery of Health Care | 9 | 2021 | 445 | 1.740 |
Why?
|
| Opioid-Related Disorders | 3 | 2020 | 298 | 1.570 |
Why?
|
| Attitude of Health Personnel | 11 | 2019 | 442 | 1.560 |
Why?
|
| Tissue and Organ Harvesting | 4 | 2015 | 49 | 1.550 |
Why?
|
| Endocarditis, Bacterial | 3 | 2021 | 32 | 1.550 |
Why?
|
| Mental Competency | 3 | 2020 | 29 | 1.540 |
Why?
|
| Clinical Competence | 6 | 2021 | 657 | 1.540 |
Why?
|
| Lung Transplantation | 2 | 2021 | 88 | 1.430 |
Why?
|
| Heart Defects, Congenital | 31 | 2021 | 596 | 1.410 |
Why?
|
| Aortic Valve Insufficiency | 7 | 2020 | 47 | 1.410 |
Why?
|
| Pandemics | 4 | 2020 | 352 | 1.380 |
Why?
|
| Industry | 6 | 2011 | 28 | 1.340 |
Why?
|
| Aortic Valve | 13 | 2020 | 249 | 1.320 |
Why?
|
| Social Responsibility | 7 | 2012 | 39 | 1.300 |
Why?
|
| International Cooperation | 3 | 2022 | 88 | 1.290 |
Why?
|
| Cardiovascular Surgical Procedures | 3 | 2017 | 36 | 1.250 |
Why?
|
| Cardiovascular System | 2 | 2022 | 85 | 1.250 |
Why?
|
| Terminal Care | 2 | 2021 | 92 | 1.240 |
Why?
|
| Medical Errors | 4 | 2014 | 80 | 1.230 |
Why?
|
| Jehovah's Witnesses | 2 | 2022 | 5 | 1.220 |
Why?
|
| Prisoners | 4 | 2021 | 50 | 1.210 |
Why?
|
| Family | 5 | 2022 | 293 | 1.200 |
Why?
|
| Health Care Rationing | 6 | 2020 | 32 | 1.190 |
Why?
|
| Capital Punishment | 3 | 2013 | 3 | 1.160 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 18 | 1.140 |
Why?
|
| Internship and Residency | 3 | 2020 | 596 | 1.120 |
Why?
|
| Ethics, Research | 4 | 2020 | 12 | 1.120 |
Why?
|
| Health Policy | 6 | 2020 | 221 | 1.090 |
Why?
|
| Physician's Role | 6 | 2010 | 116 | 1.080 |
Why?
|
| Health Services Accessibility | 4 | 2014 | 581 | 1.080 |
Why?
|
| Drug Industry | 6 | 2011 | 54 | 1.070 |
Why?
|
| Domestic Violence | 2 | 2015 | 36 | 1.020 |
Why?
|
| Heart-Assist Devices | 5 | 2020 | 221 | 1.020 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 214 | 1.000 |
Why?
|
| Consultants | 2 | 2018 | 12 | 1.000 |
Why?
|
| Professional Autonomy | 4 | 2017 | 24 | 1.000 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2017 | 99 | 0.970 |
Why?
|
| Specialties, Surgical | 2 | 2016 | 19 | 0.950 |
Why?
|
| Referral and Consultation | 3 | 2015 | 383 | 0.950 |
Why?
|
| Marketing of Health Services | 4 | 2011 | 18 | 0.940 |
Why?
|
| Social Media | 3 | 2019 | 59 | 0.920 |
Why?
|
| Research Subjects | 4 | 2019 | 45 | 0.920 |
Why?
|
| Refusal to Treat | 2 | 2016 | 2 | 0.910 |
Why?
|
| Robotics | 2 | 2014 | 56 | 0.900 |
Why?
|
| Hospitals | 3 | 2015 | 265 | 0.900 |
Why?
|
| Insurance, Health, Reimbursement | 3 | 2012 | 47 | 0.880 |
Why?
|
| Smoking | 3 | 2021 | 1452 | 0.870 |
Why?
|
| Personal Autonomy | 8 | 2012 | 22 | 0.870 |
Why?
|
| Practice Patterns, Physicians' | 6 | 2017 | 504 | 0.870 |
Why?
|
| Aortic Valve Stenosis | 6 | 2012 | 177 | 0.860 |
Why?
|
| Teaching | 3 | 2018 | 169 | 0.850 |
Why?
|
| Bioethics | 4 | 2007 | 7 | 0.840 |
Why?
|
| Central Nervous System Stimulants | 2 | 2015 | 221 | 0.840 |
Why?
|
| Advance Directives | 2 | 2016 | 22 | 0.840 |
Why?
|
| Ships | 1 | 2022 | 5 | 0.840 |
Why?
|
| Social Values | 8 | 2015 | 34 | 0.840 |
Why?
|
| Bioprosthesis | 5 | 2020 | 101 | 0.830 |
Why?
|
| Euthanasia, Active, Voluntary | 3 | 2016 | 7 | 0.820 |
Why?
|
| Transplants | 1 | 2022 | 28 | 0.820 |
Why?
|
| Suicide, Assisted | 3 | 2016 | 14 | 0.820 |
Why?
|
| Cognition | 3 | 2015 | 513 | 0.820 |
Why?
|
| Criminals | 1 | 2022 | 26 | 0.810 |
Why?
|
| Thyroxine | 1 | 2022 | 62 | 0.810 |
Why?
|
| Persuasive Communication | 1 | 2022 | 7 | 0.810 |
Why?
|
| Mitral Valve | 10 | 2018 | 166 | 0.810 |
Why?
|
| Patient Advocacy | 5 | 2019 | 40 | 0.800 |
Why?
|
| Clinical Studies as Topic | 1 | 2021 | 7 | 0.800 |
Why?
|
| Hemodynamics | 11 | 2022 | 705 | 0.800 |
Why?
|
| History, 20th Century | 11 | 2020 | 248 | 0.780 |
Why?
|
| Health Care Sector | 3 | 2011 | 26 | 0.780 |
Why?
|
| Living Donors | 3 | 2018 | 160 | 0.780 |
Why?
|
| Endocarditis | 1 | 2021 | 14 | 0.770 |
Why?
|
| Ethics | 5 | 2002 | 17 | 0.740 |
Why?
|
| Cardiac Catheterization | 7 | 2012 | 419 | 0.740 |
Why?
|
| Editorial Policies | 3 | 2020 | 32 | 0.730 |
Why?
|
| Disclosure | 4 | 2011 | 45 | 0.730 |
Why?
|
| Decision Making | 8 | 2012 | 410 | 0.720 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2021 | 931 | 0.720 |
Why?
|
| Heart Valve Diseases | 5 | 2018 | 123 | 0.720 |
Why?
|
| Insurance Coverage | 2 | 2012 | 99 | 0.710 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 27 | 0.700 |
Why?
|
| Guidelines as Topic | 3 | 2020 | 123 | 0.700 |
Why?
|
| Marijuana Use | 1 | 2020 | 35 | 0.690 |
Why?
|
| Legislation as Topic | 2 | 2019 | 6 | 0.680 |
Why?
|
| Pediatrics | 4 | 2016 | 341 | 0.680 |
Why?
|
| Cooperative Behavior | 3 | 2018 | 235 | 0.670 |
Why?
|
| Medical Records | 2 | 2012 | 121 | 0.660 |
Why?
|
| Beneficence | 4 | 2012 | 9 | 0.660 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 101 | 0.660 |
Why?
|
| Health Facilities | 2 | 2021 | 36 | 0.660 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2019 | 51 | 0.660 |
Why?
|
| Politics | 6 | 2012 | 31 | 0.650 |
Why?
|
| Gene Editing | 1 | 2019 | 33 | 0.650 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 108 | 0.650 |
Why?
|
| Clinical Trials as Topic | 6 | 2014 | 848 | 0.650 |
Why?
|
| Transplantation, Heterologous | 6 | 2022 | 122 | 0.650 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 217 | 0.640 |
Why?
|
| Surgical Procedures, Operative | 4 | 2008 | 124 | 0.640 |
Why?
|
| Gift Giving | 3 | 2007 | 10 | 0.640 |
Why?
|
| Hospital Administrators | 1 | 2018 | 10 | 0.640 |
Why?
|
| Attitude | 1 | 2019 | 121 | 0.640 |
Why?
|
| Postoperative Care | 6 | 2016 | 163 | 0.630 |
Why?
|
| Uterus | 1 | 2018 | 77 | 0.620 |
Why?
|
| Euthanasia | 2 | 2014 | 14 | 0.620 |
Why?
|
| Ethics Consultation | 1 | 2018 | 5 | 0.610 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 49 | 0.610 |
Why?
|
| Equipment Contamination | 1 | 2018 | 38 | 0.610 |
Why?
|
| Policy Making | 2 | 2018 | 51 | 0.610 |
Why?
|
| Certification | 2 | 2016 | 66 | 0.610 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 90 | 0.600 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 37 | 0.600 |
Why?
|
| Deception | 2 | 2012 | 18 | 0.600 |
Why?
|
| China | 3 | 2022 | 138 | 0.590 |
Why?
|
| Career Choice | 2 | 2021 | 98 | 0.590 |
Why?
|
| Interprofessional Relations | 5 | 2011 | 188 | 0.590 |
Why?
|
| Male | 71 | 2021 | 37321 | 0.590 |
Why?
|
| Aviation | 1 | 2017 | 13 | 0.590 |
Why?
|
| Bibliometrics | 3 | 2009 | 25 | 0.580 |
Why?
|
| Research Personnel | 2 | 2018 | 83 | 0.580 |
Why?
|
| Famous Persons | 1 | 2017 | 15 | 0.580 |
Why?
|
| Extracorporeal Circulation | 2 | 2017 | 26 | 0.580 |
Why?
|
| Global Health | 4 | 2021 | 136 | 0.580 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.570 |
Why?
|
| Female | 74 | 2020 | 38074 | 0.570 |
Why?
|
| Students, Medical | 3 | 2015 | 210 | 0.570 |
Why?
|
| Wearable Electronic Devices | 1 | 2017 | 16 | 0.560 |
Why?
|
| Athletes | 1 | 2017 | 40 | 0.560 |
Why?
|
| Firearms | 2 | 2015 | 26 | 0.560 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 168 | 0.550 |
Why?
|
| Congresses as Topic | 4 | 2020 | 85 | 0.550 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 212 | 0.550 |
Why?
|
| Human Experimentation | 2 | 2006 | 19 | 0.550 |
Why?
|
| Down Syndrome | 2 | 2017 | 120 | 0.550 |
Why?
|
| Blood Transfusion | 3 | 2022 | 205 | 0.550 |
Why?
|
| Fraud | 2 | 2016 | 8 | 0.540 |
Why?
|
| Cross Infection | 1 | 2018 | 195 | 0.540 |
Why?
|
| Ethics, Clinical | 5 | 2010 | 9 | 0.540 |
Why?
|
| Trust | 5 | 2011 | 75 | 0.530 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 72 | 0.530 |
Why?
|
| Specialty Boards | 1 | 2016 | 24 | 0.530 |
Why?
|
| Withholding Treatment | 3 | 2016 | 35 | 0.530 |
Why?
|
| National Health Insurance, United States | 3 | 2012 | 6 | 0.520 |
Why?
|
| Child | 52 | 2022 | 6405 | 0.520 |
Why?
|
| Risk Assessment | 8 | 2018 | 2007 | 0.520 |
Why?
|
| Professional Competence | 1 | 2016 | 100 | 0.510 |
Why?
|
| South Carolina | 17 | 2019 | 2752 | 0.510 |
Why?
|
| Research Support as Topic | 4 | 2011 | 58 | 0.510 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 283 | 0.510 |
Why?
|
| Blood Circulation | 2 | 2014 | 18 | 0.500 |
Why?
|
| Drug Users | 1 | 2015 | 10 | 0.500 |
Why?
|
| Performance-Enhancing Substances | 1 | 2015 | 2 | 0.500 |
Why?
|
| Nootropic Agents | 1 | 2015 | 18 | 0.500 |
Why?
|
| Tissue Survival | 1 | 2015 | 22 | 0.500 |
Why?
|
| Research Design | 5 | 2016 | 729 | 0.500 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 277 | 0.500 |
Why?
|
| Program Development | 2 | 2016 | 240 | 0.490 |
Why?
|
| Caffeine | 1 | 2015 | 81 | 0.490 |
Why?
|
| Disabled Children | 1 | 2014 | 16 | 0.480 |
Why?
|
| Patient Transfer | 1 | 2015 | 86 | 0.480 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2012 | 59 | 0.480 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2014 | 37 | 0.470 |
Why?
|
| Prescription Drugs | 1 | 2015 | 71 | 0.470 |
Why?
|
| Persistent Vegetative State | 1 | 2014 | 5 | 0.470 |
Why?
|
| Mutation | 1 | 2019 | 1213 | 0.460 |
Why?
|
| Pulmonary Artery | 21 | 1994 | 323 | 0.460 |
Why?
|
| Aortic Coarctation | 8 | 1998 | 37 | 0.460 |
Why?
|
| Neurosciences | 1 | 2014 | 15 | 0.460 |
Why?
|
| Off-Label Use | 1 | 2014 | 17 | 0.460 |
Why?
|
| Public Opinion | 1 | 2014 | 32 | 0.460 |
Why?
|
| Terminology as Topic | 4 | 2011 | 141 | 0.460 |
Why?
|
| Surgicenters | 1 | 2013 | 3 | 0.450 |
Why?
|
| Military Personnel | 1 | 2016 | 221 | 0.450 |
Why?
|
| Access to Information | 3 | 2010 | 21 | 0.440 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 565 | 0.440 |
Why?
|
| Employment | 1 | 2014 | 154 | 0.440 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 1242 | 0.440 |
Why?
|
| Education, Medical | 2 | 2014 | 147 | 0.440 |
Why?
|
| Postoperative Complications | 31 | 2009 | 1615 | 0.430 |
Why?
|
| Patient Rights | 3 | 2016 | 11 | 0.430 |
Why?
|
| Managed Care Programs | 3 | 2001 | 45 | 0.430 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 61 | 0.430 |
Why?
|
| Heart Failure | 11 | 2017 | 1180 | 0.420 |
Why?
|
| Sleep Deprivation | 1 | 2013 | 81 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 767 | 0.420 |
Why?
|
| Hepacivirus | 1 | 2013 | 90 | 0.410 |
Why?
|
| Attitude to Death | 3 | 2021 | 52 | 0.410 |
Why?
|
| Supreme Court Decisions | 1 | 2012 | 3 | 0.410 |
Why?
|
| Ethical Theory | 1 | 2012 | 4 | 0.410 |
Why?
|
| Population Dynamics | 1 | 2012 | 30 | 0.400 |
Why?
|
| Exsanguination | 1 | 2011 | 8 | 0.400 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 21 | 0.400 |
Why?
|
| Professional Corporations | 1 | 2011 | 2 | 0.400 |
Why?
|
| Practice Guidelines as Topic | 5 | 2020 | 772 | 0.400 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 86 | 0.400 |
Why?
|
| Coronary Artery Bypass | 3 | 2018 | 218 | 0.390 |
Why?
|
| Financial Management | 1 | 2011 | 10 | 0.390 |
Why?
|
| Cardiopulmonary Bypass | 11 | 2000 | 250 | 0.390 |
Why?
|
| Donor Selection | 1 | 2011 | 29 | 0.380 |
Why?
|
| Life Support Care | 1 | 2011 | 12 | 0.380 |
Why?
|
| Interinstitutional Relations | 1 | 2011 | 49 | 0.380 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 136 | 0.380 |
Why?
|
| Reoperation | 12 | 2020 | 467 | 0.380 |
Why?
|
| Adult | 36 | 2022 | 21403 | 0.370 |
Why?
|
| Internet | 2 | 2012 | 390 | 0.370 |
Why?
|
| Television | 2 | 2008 | 28 | 0.370 |
Why?
|
| Human Characteristics | 2 | 2008 | 3 | 0.360 |
Why?
|
| Criminal Law | 2 | 2007 | 30 | 0.360 |
Why?
|
| Medicare | 1 | 2012 | 319 | 0.360 |
Why?
|
| American Medical Association | 5 | 2008 | 21 | 0.350 |
Why?
|
| Commitment of Mentally Ill | 1 | 2010 | 15 | 0.350 |
Why?
|
| Insanity Defense | 1 | 2010 | 11 | 0.350 |
Why?
|
| Government Regulation | 4 | 2016 | 46 | 0.350 |
Why?
|
| Disabled Persons | 1 | 2011 | 94 | 0.350 |
Why?
|
| Communication | 1 | 2012 | 329 | 0.350 |
Why?
|
| Infant | 52 | 2019 | 2891 | 0.340 |
Why?
|
| Forensic Psychiatry | 1 | 2010 | 36 | 0.340 |
Why?
|
| Newspapers as Topic | 1 | 2009 | 2 | 0.330 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2009 | 30 | 0.330 |
Why?
|
| Tricuspid Valve | 8 | 1993 | 42 | 0.330 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 70 | 0.320 |
Why?
|
| Professional-Family Relations | 1 | 2009 | 45 | 0.320 |
Why?
|
| Retraction of Publication as Topic | 2 | 2020 | 2 | 0.320 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 425 | 0.320 |
Why?
|
| Audiovisual Aids | 1 | 2008 | 20 | 0.320 |
Why?
|
| Patient Care | 2 | 2006 | 61 | 0.310 |
Why?
|
| Religion and Science | 1 | 2008 | 1 | 0.310 |
Why?
|
| Biomedical Enhancement | 1 | 2008 | 1 | 0.310 |
Why?
|
| Quarantine | 1 | 2008 | 3 | 0.310 |
Why?
|
| Single-Payer System | 1 | 2007 | 3 | 0.300 |
Why?
|
| Parents | 1 | 2011 | 312 | 0.300 |
Why?
|
| Religion and Medicine | 1 | 2008 | 25 | 0.300 |
Why?
|
| Patient Isolation | 1 | 2008 | 35 | 0.300 |
Why?
|
| Lung Neoplasms | 4 | 2021 | 1173 | 0.300 |
Why?
|
| Patient Selection | 6 | 2019 | 592 | 0.300 |
Why?
|
| Palliative Care | 8 | 2019 | 271 | 0.300 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 121 | 0.300 |
Why?
|
| Culture | 1 | 2008 | 75 | 0.300 |
Why?
|
| Infant, Newborn | 25 | 2014 | 2455 | 0.290 |
Why?
|
| Research | 2 | 2014 | 214 | 0.290 |
Why?
|
| Fees and Charges | 2 | 2009 | 11 | 0.290 |
Why?
|
| Propranolol | 1 | 2007 | 103 | 0.290 |
Why?
|
| Medical Futility | 3 | 2016 | 31 | 0.290 |
Why?
|
| History, 19th Century | 3 | 2017 | 95 | 0.290 |
Why?
|
| Biomedical Technology | 1 | 2007 | 14 | 0.280 |
Why?
|
| Therapies, Investigational | 1 | 2006 | 6 | 0.280 |
Why?
|
| Child, Preschool | 45 | 2012 | 3187 | 0.280 |
Why?
|
| Codes of Ethics | 3 | 2019 | 11 | 0.280 |
Why?
|
| Patient Safety | 2 | 2018 | 202 | 0.280 |
Why?
|
| Surgical Mesh | 1 | 2006 | 57 | 0.270 |
Why?
|
| Beginning of Human Life | 1 | 2006 | 1 | 0.270 |
Why?
|
| Electronic Health Records | 1 | 2010 | 374 | 0.270 |
Why?
|
| Personhood | 1 | 2006 | 4 | 0.270 |
Why?
|
| Patient Dropouts | 1 | 2007 | 98 | 0.270 |
Why?
|
| Hospital Planning | 1 | 2005 | 2 | 0.270 |
Why?
|
| Hospitals, Special | 1 | 2005 | 15 | 0.260 |
Why?
|
| Memory | 1 | 2007 | 214 | 0.260 |
Why?
|
| Idarubicin | 1 | 2005 | 4 | 0.260 |
Why?
|
| Quality of Health Care | 2 | 2007 | 322 | 0.250 |
Why?
|
| Pacemaker, Artificial | 6 | 1994 | 157 | 0.250 |
Why?
|
| Minority Groups | 1 | 2007 | 197 | 0.250 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 82 | 0.250 |
Why?
|
| Genetic Research | 2 | 2002 | 16 | 0.250 |
Why?
|
| Organizational Policy | 3 | 2007 | 42 | 0.250 |
Why?
|
| Nobel Prize | 2 | 2017 | 2 | 0.250 |
Why?
|
| Curriculum | 3 | 2020 | 575 | 0.250 |
Why?
|
| Transposition of Great Vessels | 11 | 1992 | 51 | 0.240 |
Why?
|
| Middle Aged | 22 | 2021 | 21147 | 0.240 |
Why?
|
| Cardiomyopathies | 2 | 2005 | 167 | 0.240 |
Why?
|
| Hypothermia, Induced | 4 | 2021 | 93 | 0.240 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2005 | 116 | 0.240 |
Why?
|
| Mental Disorders | 1 | 2010 | 659 | 0.230 |
Why?
|
| Telemedicine | 1 | 2012 | 700 | 0.230 |
Why?
|
| Resource Allocation | 3 | 2019 | 35 | 0.230 |
Why?
|
| Medical Laboratory Science | 2 | 2002 | 8 | 0.230 |
Why?
|
| Recurrence | 3 | 2021 | 948 | 0.230 |
Why?
|
| Human Rights | 6 | 2006 | 12 | 0.220 |
Why?
|
| Genetic Engineering | 3 | 1998 | 41 | 0.220 |
Why?
|
| Aggression | 1 | 2004 | 98 | 0.220 |
Why?
|
| Heart-Lung Transplantation | 1 | 2003 | 2 | 0.220 |
Why?
|
| Ethical Analysis | 2 | 2006 | 5 | 0.220 |
Why?
|
| Young Adult | 3 | 2020 | 5717 | 0.220 |
Why?
|
| Adolescent | 35 | 2021 | 8912 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2003 | 22 | 0.220 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 378 | 0.220 |
Why?
|
| Judgment | 2 | 2015 | 40 | 0.220 |
Why?
|
| Cadaver | 2 | 2003 | 136 | 0.210 |
Why?
|
| Brain | 3 | 2022 | 2176 | 0.210 |
Why?
|
| France | 2 | 2017 | 26 | 0.210 |
Why?
|
| Commerce | 2 | 2020 | 80 | 0.210 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2007 | 189 | 0.210 |
Why?
|
| Treatment Outcome | 9 | 2021 | 7029 | 0.210 |
Why?
|
| Preservation, Biological | 1 | 2002 | 11 | 0.210 |
Why?
|
| Complementary Therapies | 1 | 2003 | 43 | 0.210 |
Why?
|
| Methylprednisolone | 2 | 2022 | 99 | 0.210 |
Why?
|
| Quality of Life | 1 | 2011 | 1515 | 0.210 |
Why?
|
| Professionalism | 2 | 2019 | 28 | 0.210 |
Why?
|
| Consanguinity | 1 | 2022 | 12 | 0.210 |
Why?
|
| Zoonoses | 1 | 2022 | 12 | 0.210 |
Why?
|
| Neurosurgery | 1 | 2002 | 42 | 0.200 |
Why?
|
| Eugenics | 2 | 1998 | 4 | 0.200 |
Why?
|
| Insurance Claim Reporting | 1 | 2001 | 10 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2006 | 622 | 0.200 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 107 | 0.200 |
Why?
|
| Violence | 1 | 2004 | 275 | 0.200 |
Why?
|
| School Admission Criteria | 3 | 1995 | 36 | 0.200 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 83 | 0.190 |
Why?
|
| Follow-Up Studies | 18 | 2019 | 3259 | 0.190 |
Why?
|
| Freedom | 4 | 2012 | 9 | 0.190 |
Why?
|
| Vulnerable Populations | 2 | 2018 | 84 | 0.190 |
Why?
|
| Swine | 3 | 2022 | 672 | 0.190 |
Why?
|
| Motivation | 3 | 2003 | 561 | 0.190 |
Why?
|
| Prosthesis Design | 6 | 2018 | 301 | 0.190 |
Why?
|
| Stress, Psychological | 3 | 2020 | 824 | 0.190 |
Why?
|
| Information Management | 1 | 2001 | 23 | 0.190 |
Why?
|
| Forecasting | 3 | 2017 | 277 | 0.180 |
Why?
|
| Aorta | 6 | 1987 | 316 | 0.180 |
Why?
|
| Interdisciplinary Communication | 2 | 2018 | 93 | 0.180 |
Why?
|
| Disease Progression | 2 | 2017 | 1038 | 0.180 |
Why?
|
| Insurance, Health | 1 | 2001 | 201 | 0.180 |
Why?
|
| Thrombosis | 5 | 2006 | 218 | 0.180 |
Why?
|
| Tetralogy of Fallot | 10 | 1991 | 43 | 0.180 |
Why?
|
| Racism | 1 | 2021 | 59 | 0.170 |
Why?
|
| Ductus Arteriosus, Patent | 8 | 1989 | 38 | 0.170 |
Why?
|
| Patient Participation | 1 | 2001 | 146 | 0.170 |
Why?
|
| Directed Tissue Donation | 1 | 1999 | 5 | 0.170 |
Why?
|
| Cicatrix | 1 | 2019 | 60 | 0.170 |
Why?
|
| History, 21st Century | 3 | 2011 | 127 | 0.170 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 17 | 0.170 |
Why?
|
| Aged | 12 | 2021 | 14862 | 0.170 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 149 | 0.160 |
Why?
|
| Genetic Therapy | 2 | 1998 | 291 | 0.160 |
Why?
|
| Policy | 1 | 2019 | 58 | 0.160 |
Why?
|
| Heart Bypass, Right | 2 | 1995 | 30 | 0.160 |
Why?
|
| Genetic Enhancement | 1 | 1998 | 3 | 0.160 |
Why?
|
| Learning Curve | 1 | 2018 | 20 | 0.160 |
Why?
|
| Students | 2 | 2021 | 233 | 0.160 |
Why?
|
| Heart Atria | 7 | 1994 | 206 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 11 | 1991 | 59 | 0.160 |
Why?
|
| Right to Die | 2 | 2016 | 5 | 0.160 |
Why?
|
| Fontan Procedure | 1 | 2019 | 129 | 0.150 |
Why?
|
| Basal Ganglia Diseases | 1 | 1998 | 13 | 0.150 |
Why?
|
| Propanolamines | 1 | 1998 | 70 | 0.150 |
Why?
|
| Workload | 1 | 2018 | 103 | 0.150 |
Why?
|
| Critical Care | 1 | 2020 | 263 | 0.150 |
Why?
|
| History, 18th Century | 2 | 2011 | 26 | 0.150 |
Why?
|
| National Socialism | 1 | 2017 | 11 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2018 | 108 | 0.140 |
Why?
|
| Kidney | 1 | 2002 | 945 | 0.140 |
Why?
|
| Cholesterol | 1 | 2018 | 331 | 0.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 1506 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2018 | 206 | 0.140 |
Why?
|
| Philosophy, Medical | 2 | 1995 | 12 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 454 | 0.140 |
Why?
|
| Attitude to Health | 3 | 2009 | 403 | 0.140 |
Why?
|
| Ethics Committees, Research | 2 | 2006 | 22 | 0.140 |
Why?
|
| Sports | 1 | 2017 | 55 | 0.140 |
Why?
|
| Animals | 11 | 2022 | 20881 | 0.140 |
Why?
|
| Pain | 1 | 2000 | 472 | 0.140 |
Why?
|
| Confusion | 1 | 2016 | 20 | 0.140 |
Why?
|
| Reference Standards | 2 | 2019 | 115 | 0.140 |
Why?
|
| Civil Rights | 3 | 2008 | 10 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2000 | 239 | 0.130 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 123 | 0.130 |
Why?
|
| Lawyers | 1 | 1996 | 4 | 0.130 |
Why?
|
| Prognosis | 5 | 2012 | 2093 | 0.130 |
Why?
|
| Military Medicine | 1 | 2016 | 53 | 0.130 |
Why?
|
| Health | 1 | 1995 | 26 | 0.130 |
Why?
|
| Disease | 1 | 1995 | 41 | 0.130 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 13 | 0.130 |
Why?
|
| Universities | 1 | 2017 | 191 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2016 | 172 | 0.130 |
Why?
|
| Publication Bias | 1 | 2015 | 8 | 0.130 |
Why?
|
| Resuscitation Orders | 1 | 1995 | 12 | 0.130 |
Why?
|
| Helsinki Declaration | 2 | 2006 | 4 | 0.120 |
Why?
|
| Authorship | 1 | 2015 | 18 | 0.120 |
Why?
|
| Heart Ventricles | 11 | 1994 | 738 | 0.120 |
Why?
|
| Personality | 1 | 1995 | 66 | 0.120 |
Why?
|
| Genetic Privacy | 2 | 2004 | 3 | 0.120 |
Why?
|
| Genetic Techniques | 1 | 1994 | 32 | 0.120 |
Why?
|
| Subcutaneous Emphysema | 1 | 1994 | 1 | 0.120 |
Why?
|
| Interviews as Topic | 2 | 1995 | 392 | 0.120 |
Why?
|
| Anticoagulants | 4 | 2006 | 356 | 0.120 |
Why?
|
| Public Health | 2 | 2008 | 201 | 0.120 |
Why?
|
| Bias | 1 | 2015 | 148 | 0.120 |
Why?
|
| Therapeutic Misconception | 1 | 2014 | 2 | 0.120 |
Why?
|
| Fee Schedules | 1 | 1993 | 2 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 1994 | 20 | 0.120 |
Why?
|
| Hydroxyethyl Starch Derivatives | 2 | 1985 | 24 | 0.120 |
Why?
|
| Starch | 2 | 1985 | 18 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 150 | 0.120 |
Why?
|
| HIV Infections | 1 | 2002 | 791 | 0.110 |
Why?
|
| Liver | 1 | 2019 | 1118 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 274 | 0.110 |
Why?
|
| Drug Prescriptions | 1 | 2015 | 135 | 0.110 |
Why?
|
| Abnormalities, Multiple | 3 | 1992 | 109 | 0.110 |
Why?
|
| Echocardiography | 10 | 1991 | 515 | 0.110 |
Why?
|
| Physician Impairment | 1 | 2013 | 3 | 0.110 |
Why?
|
| Pulmonary Circulation | 5 | 1990 | 79 | 0.110 |
Why?
|
| Hippocratic Oath | 1 | 2012 | 1 | 0.110 |
Why?
|
| Retrospective Studies | 12 | 2006 | 7277 | 0.110 |
Why?
|
| Licensure | 1 | 2012 | 18 | 0.110 |
Why?
|
| Standard of Care | 1 | 2012 | 22 | 0.100 |
Why?
|
| Capitalism | 1 | 2012 | 2 | 0.100 |
Why?
|
| Electronic Mail | 1 | 2012 | 29 | 0.100 |
Why?
|
| Coercion | 1 | 2012 | 11 | 0.100 |
Why?
|
| Biopsy | 1 | 2014 | 540 | 0.100 |
Why?
|
| Negotiating | 1 | 2012 | 18 | 0.100 |
Why?
|
| Total Quality Management | 2 | 2009 | 45 | 0.100 |
Why?
|
| Organ Preservation | 2 | 2022 | 69 | 0.100 |
Why?
|
| Warfarin | 2 | 2006 | 93 | 0.100 |
Why?
|
| United Kingdom | 1 | 2012 | 152 | 0.100 |
Why?
|
| Animal Experimentation | 1 | 2011 | 3 | 0.100 |
Why?
|
| Perfusion | 2 | 2022 | 131 | 0.100 |
Why?
|
| Income | 1 | 2012 | 167 | 0.100 |
Why?
|
| Professional Misconduct | 1 | 2011 | 1 | 0.100 |
Why?
|
| Prenatal Diagnosis | 2 | 1989 | 73 | 0.100 |
Why?
|
| Intracranial Hypotension | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2011 | 13 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 300 | 0.100 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2011 | 19 | 0.100 |
Why?
|
| Organizational Innovation | 1 | 2011 | 55 | 0.100 |
Why?
|
| Oxygenators | 2 | 1981 | 6 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 81 | 0.090 |
Why?
|
| Oxygenators, Membrane | 2 | 1981 | 5 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2011 | 31 | 0.090 |
Why?
|
| Uncertainty | 1 | 2011 | 31 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 629 | 0.090 |
Why?
|
| Pregnancy | 3 | 2014 | 2334 | 0.090 |
Why?
|
| Time Factors | 11 | 2010 | 4655 | 0.090 |
Why?
|
| Health Care Costs | 1 | 1993 | 346 | 0.090 |
Why?
|
| Chylothorax | 1 | 1990 | 11 | 0.090 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 17 | 0.090 |
Why?
|
| Intraocular Pressure | 1 | 2011 | 143 | 0.090 |
Why?
|
| Prospective Studies | 11 | 2006 | 3705 | 0.090 |
Why?
|
| Waiting Lists | 2 | 2003 | 104 | 0.090 |
Why?
|
| Equipment Failure | 3 | 1994 | 112 | 0.090 |
Why?
|
| Educational Measurement | 3 | 1995 | 254 | 0.090 |
Why?
|
| Social Environment | 1 | 2011 | 182 | 0.090 |
Why?
|
| Dangerous Behavior | 1 | 2010 | 8 | 0.090 |
Why?
|
| Aorta, Thoracic | 7 | 1996 | 211 | 0.090 |
Why?
|
| Equipment Design | 1 | 2011 | 500 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2006 | 373 | 0.090 |
Why?
|
| Ownership | 2 | 2002 | 18 | 0.090 |
Why?
|
| Injections | 3 | 2007 | 119 | 0.090 |
Why?
|
| Philosophy | 2 | 2001 | 4 | 0.090 |
Why?
|
| Genetic Counseling | 2 | 2004 | 45 | 0.090 |
Why?
|
| Ultrasonography | 2 | 1989 | 453 | 0.090 |
Why?
|
| Social Support | 1 | 2012 | 423 | 0.080 |
Why?
|
| Aortic Stenosis, Subvalvular | 4 | 1990 | 8 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2010 | 239 | 0.080 |
Why?
|
| Homicide | 1 | 2010 | 59 | 0.080 |
Why?
|
| Pulmonary Valve Stenosis | 3 | 1993 | 16 | 0.080 |
Why?
|
| Life Support Systems | 1 | 2009 | 1 | 0.080 |
Why?
|
| Lung | 6 | 1995 | 849 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2010 | 115 | 0.080 |
Why?
|
| Vena Cava, Superior | 3 | 1995 | 41 | 0.080 |
Why?
|
| Blood Vessel Prosthesis | 3 | 1987 | 182 | 0.080 |
Why?
|
| North Carolina | 2 | 2014 | 224 | 0.080 |
Why?
|
| Hypertension | 1 | 1998 | 1535 | 0.080 |
Why?
|
| Videotape Recording | 1 | 2008 | 43 | 0.080 |
Why?
|
| Pneumonectomy | 1 | 2009 | 79 | 0.080 |
Why?
|
| Schizophrenia | 1 | 2010 | 206 | 0.080 |
Why?
|
| Facial Transplantation | 1 | 2008 | 1 | 0.080 |
Why?
|
| Genetics, Behavioral | 1 | 2008 | 2 | 0.080 |
Why?
|
| Disease Notification | 1 | 2008 | 7 | 0.080 |
Why?
|
| Isotonic Solutions | 2 | 1985 | 25 | 0.080 |
Why?
|
| Therapeutic Human Experimentation | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 1990 | 116 | 0.080 |
Why?
|
| Ethics Committees | 1 | 2007 | 4 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2009 | 174 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 468 | 0.080 |
Why?
|
| State Government | 1 | 2007 | 34 | 0.070 |
Why?
|
| Nuclear Family | 1 | 2007 | 16 | 0.070 |
Why?
|
| Community Participation | 1 | 2008 | 42 | 0.070 |
Why?
|
| Methods | 10 | 1984 | 156 | 0.070 |
Why?
|
| Placebos | 1 | 2008 | 195 | 0.070 |
Why?
|
| Marketing | 1 | 2007 | 26 | 0.070 |
Why?
|
| Isosorbide Dinitrate | 1 | 2007 | 6 | 0.070 |
Why?
|
| Hydralazine | 1 | 2007 | 12 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2008 | 127 | 0.070 |
Why?
|
| Video Recording | 1 | 2008 | 145 | 0.070 |
Why?
|
| Heart Arrest, Induced | 4 | 2021 | 52 | 0.070 |
Why?
|
| Prejudice | 1 | 2007 | 37 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2007 | 73 | 0.070 |
Why?
|
| Chimera | 1 | 2007 | 33 | 0.070 |
Why?
|
| Drug Approval | 1 | 2007 | 50 | 0.070 |
Why?
|
| Peer Review | 1 | 2006 | 16 | 0.070 |
Why?
|
| Pulmonary Valve | 5 | 1994 | 40 | 0.070 |
Why?
|
| Pericardium | 2 | 1986 | 97 | 0.070 |
Why?
|
| Heart Diseases | 4 | 1994 | 276 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2009 | 402 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 131 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4848 | 0.070 |
Why?
|
| Peer Review, Research | 1 | 2006 | 21 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 955 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2007 | 304 | 0.070 |
Why?
|
| Heart Septal Defects | 2 | 1990 | 27 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2007 | 220 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 202 | 0.070 |
Why?
|
| Health Priorities | 1 | 2006 | 23 | 0.070 |
Why?
|
| Embolism | 1 | 2006 | 45 | 0.070 |
Why?
|
| Transplantation | 1 | 2006 | 23 | 0.070 |
Why?
|
| Cytarabine | 1 | 2005 | 44 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2005 | 504 | 0.060 |
Why?
|
| Paternalism | 2 | 2006 | 6 | 0.060 |
Why?
|
| Cultural Diversity | 2 | 1999 | 67 | 0.060 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 77 | 0.060 |
Why?
|
| Vena Cava, Inferior | 3 | 1995 | 41 | 0.060 |
Why?
|
| Albumins | 1 | 1985 | 72 | 0.060 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 15 | 0.060 |
Why?
|
| Cardiology | 1 | 2006 | 140 | 0.060 |
Why?
|
| Echocardiography, Doppler | 4 | 1994 | 87 | 0.060 |
Why?
|
| Hormones | 1 | 2004 | 42 | 0.060 |
Why?
|
| Data Collection | 1 | 2006 | 420 | 0.060 |
Why?
|
| Cardiac Output | 3 | 1990 | 133 | 0.060 |
Why?
|
| Paraplegia | 1 | 1984 | 28 | 0.060 |
Why?
|
| Atrial Flutter | 2 | 1994 | 16 | 0.060 |
Why?
|
| Coronary Vessel Anomalies | 2 | 1987 | 45 | 0.060 |
Why?
|
| Subclavian Artery | 3 | 1987 | 30 | 0.060 |
Why?
|
| Motion Pictures | 1 | 2004 | 8 | 0.060 |
Why?
|
| Heart Injuries | 2 | 1983 | 25 | 0.060 |
Why?
|
| Povidone | 1 | 1983 | 12 | 0.060 |
Why?
|
| Povidone-Iodine | 1 | 1983 | 16 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2006 | 287 | 0.060 |
Why?
|
| Pulmonary Veins | 5 | 1979 | 56 | 0.060 |
Why?
|
| Education, Premedical | 1 | 1983 | 3 | 0.060 |
Why?
|
| Genomics | 1 | 2004 | 168 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 786 | 0.060 |
Why?
|
| Virtues | 2 | 1996 | 3 | 0.060 |
Why?
|
| Plastics | 1 | 1983 | 25 | 0.060 |
Why?
|
| Polyglycolic Acid | 1 | 1983 | 20 | 0.060 |
Why?
|
| Embolism, Air | 1 | 1983 | 16 | 0.060 |
Why?
|
| Fever | 1 | 1984 | 96 | 0.060 |
Why?
|
| Blood Pressure | 7 | 2011 | 1451 | 0.060 |
Why?
|
| Family Health | 1 | 2004 | 83 | 0.060 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2003 | 8 | 0.060 |
Why?
|
| Intuition | 1 | 2003 | 1 | 0.060 |
Why?
|
| Game Theory | 1 | 2003 | 7 | 0.060 |
Why?
|
| Budgets | 1 | 2003 | 12 | 0.050 |
Why?
|
| Prisons | 1 | 2003 | 18 | 0.050 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2003 | 3 | 0.050 |
Why?
|
| Polypropylenes | 1 | 1983 | 31 | 0.050 |
Why?
|
| Spinal Cord | 1 | 1984 | 244 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2003 | 164 | 0.050 |
Why?
|
| Kidney Transplantation | 2 | 2002 | 839 | 0.050 |
Why?
|
| Plasma Substitutes | 1 | 1982 | 15 | 0.050 |
Why?
|
| Commodification | 1 | 2002 | 1 | 0.050 |
Why?
|
| Wedge Argument | 1 | 2002 | 2 | 0.050 |
Why?
|
| Blood Donors | 1 | 2002 | 18 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 468 | 0.050 |
Why?
|
| Guatemala | 2 | 2006 | 9 | 0.050 |
Why?
|
| Absenteeism | 1 | 1982 | 27 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2003 | 150 | 0.050 |
Why?
|
| Boston | 1 | 2021 | 35 | 0.050 |
Why?
|
| Pericardial Effusion | 3 | 1978 | 15 | 0.050 |
Why?
|
| Biomarkers | 1 | 2007 | 1593 | 0.050 |
Why?
|
| Education, Medical, Undergraduate | 2 | 1999 | 148 | 0.050 |
Why?
|
| Radionuclide Imaging | 5 | 1990 | 166 | 0.050 |
Why?
|
| American Heart Association | 1 | 2021 | 142 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1981 | 113 | 0.050 |
Why?
|
| Schools, Medical | 1 | 1982 | 157 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 1984 | 37 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 117 | 0.050 |
Why?
|
| Plagiarism | 1 | 2020 | 2 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 13 | 0.040 |
Why?
|
| Surge Capacity | 1 | 2020 | 6 | 0.040 |
Why?
|
| Heart Septum | 3 | 1993 | 84 | 0.040 |
Why?
|
| Legislation, Medical | 1 | 2000 | 8 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2006 | 2358 | 0.040 |
Why?
|
| National Health Programs | 1 | 1979 | 11 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 1980 | 138 | 0.040 |
Why?
|
| Europe | 1 | 2000 | 196 | 0.040 |
Why?
|
| Pericarditis | 2 | 1976 | 3 | 0.040 |
Why?
|
| Magnesium | 1 | 2000 | 110 | 0.040 |
Why?
|
| Haemophilus influenzae | 2 | 1976 | 16 | 0.040 |
Why?
|
| Cyanosis | 2 | 1998 | 4 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 1979 | 44 | 0.040 |
Why?
|
| Human Body | 1 | 1999 | 2 | 0.040 |
Why?
|
| Attitude to Computers | 1 | 2019 | 38 | 0.040 |
Why?
|
| Health Resources | 1 | 2019 | 76 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 190 | 0.040 |
Why?
|
| Social Justice | 1 | 1999 | 32 | 0.040 |
Why?
|
| Developing Countries | 1 | 2019 | 106 | 0.040 |
Why?
|
| Germ Cells | 1 | 1998 | 17 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 1999 | 74 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 1745 | 0.040 |
Why?
|
| Postpericardiotomy Syndrome | 1 | 1978 | 1 | 0.040 |
Why?
|
| Heart Block | 3 | 1994 | 49 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2000 | 1330 | 0.040 |
Why?
|
| Tachycardia, Ectopic Junctional | 2 | 2000 | 4 | 0.040 |
Why?
|
| Dipyridamole | 1 | 1997 | 26 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 137 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 306 | 0.040 |
Why?
|
| Taxes | 1 | 1997 | 31 | 0.040 |
Why?
|
| Intraoperative Care | 2 | 1991 | 91 | 0.030 |
Why?
|
| Haemophilus Infections | 1 | 1976 | 15 | 0.030 |
Why?
|
| Esophageal Fistula | 1 | 1996 | 7 | 0.030 |
Why?
|
| Thromboembolism | 5 | 1997 | 91 | 0.030 |
Why?
|
| Value of Life | 1 | 1996 | 14 | 0.030 |
Why?
|
| Syndrome | 2 | 1987 | 255 | 0.030 |
Why?
|
| Catheterization | 2 | 1996 | 209 | 0.030 |
Why?
|
| Fistula | 1 | 1996 | 29 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1995 | 737 | 0.030 |
Why?
|
| Therapeutics | 1 | 1995 | 7 | 0.030 |
Why?
|
| Diagnosis | 1 | 1995 | 15 | 0.030 |
Why?
|
| Aspirin | 1 | 1997 | 295 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2000 | 1342 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 2223 | 0.030 |
Why?
|
| Drainage | 3 | 1990 | 133 | 0.030 |
Why?
|
| Cor Triatriatum | 1 | 1995 | 5 | 0.030 |
Why?
|
| Length of Stay | 2 | 1990 | 780 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 1996 | 113 | 0.030 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 1974 | 7 | 0.030 |
Why?
|
| Radiography | 3 | 1990 | 572 | 0.030 |
Why?
|
| Suicide | 1 | 1996 | 116 | 0.030 |
Why?
|
| Anastomosis, Surgical | 2 | 1994 | 104 | 0.030 |
Why?
|
| Insurance Pools | 1 | 1994 | 1 | 0.030 |
Why?
|
| Vascular Resistance | 3 | 1981 | 179 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1995 | 100 | 0.030 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 1994 | 24 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 2 | 1987 | 55 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2002 | 2800 | 0.030 |
Why?
|
| Venous Insufficiency | 1 | 1974 | 27 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1994 | 43 | 0.030 |
Why?
|
| Cryopreservation | 1 | 1994 | 103 | 0.030 |
Why?
|
| Mitral Valve Stenosis | 1 | 1993 | 15 | 0.030 |
Why?
|
| Esophageal Diseases | 1 | 1994 | 95 | 0.030 |
Why?
|
| Thorax | 2 | 1991 | 49 | 0.030 |
Why?
|
| Genetic Testing | 1 | 1994 | 159 | 0.030 |
Why?
|
| Random Allocation | 3 | 1985 | 442 | 0.030 |
Why?
|
| Electrocardiography | 2 | 1994 | 601 | 0.030 |
Why?
|
| Esophagus | 2 | 1991 | 303 | 0.030 |
Why?
|
| Health Services | 1 | 1974 | 87 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2006 | 714 | 0.030 |
Why?
|
| Rabbits | 2 | 1983 | 509 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1995 | 1040 | 0.030 |
Why?
|
| Actuarial Analysis | 2 | 2003 | 23 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2012 | 238 | 0.030 |
Why?
|
| Personal Health Services | 1 | 1971 | 1 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 281 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1992 | 174 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1974 | 232 | 0.020 |
Why?
|
| Sex Factors | 1 | 1995 | 1266 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 563 | 0.020 |
Why?
|
| Streptokinase | 1 | 1991 | 23 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1995 | 1465 | 0.020 |
Why?
|
| Visual Fields | 1 | 2011 | 41 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 2011 | 38 | 0.020 |
Why?
|
| Psychometrics | 1 | 2014 | 514 | 0.020 |
Why?
|
| Ligation | 3 | 1987 | 83 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 1990 | 25 | 0.020 |
Why?
|
| Pleura | 1 | 1990 | 25 | 0.020 |
Why?
|
| Hospitals, University | 2 | 2006 | 169 | 0.020 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1990 | 36 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 5 | 1991 | 219 | 0.020 |
Why?
|
| Formaldehyde | 2 | 1980 | 48 | 0.020 |
Why?
|
| Respiratory Paralysis | 2 | 1987 | 10 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 2077 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1991 | 233 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2008 | 20 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1998 | 2324 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 3 | 1977 | 8 | 0.020 |
Why?
|
| Suture Techniques | 2 | 1981 | 75 | 0.020 |
Why?
|
| Heart Neoplasms | 1 | 1986 | 33 | 0.020 |
Why?
|
| Papio | 1 | 1986 | 27 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 1986 | 64 | 0.020 |
Why?
|
| Diaphragmatic Eventration | 1 | 1986 | 9 | 0.020 |
Why?
|
| Hemangioma | 1 | 1986 | 51 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 2006 | 26 | 0.020 |
Why?
|
| Risk Factors | 3 | 1994 | 5731 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 349 | 0.020 |
Why?
|
| Body Fluids | 1 | 1985 | 41 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 1985 | 44 | 0.020 |
Why?
|
| Colloids | 1 | 1985 | 43 | 0.020 |
Why?
|
| Prosthesis Failure | 2 | 1999 | 130 | 0.020 |
Why?
|
| Airway Obstruction | 2 | 1996 | 49 | 0.020 |
Why?
|
| Cineangiography | 2 | 1987 | 15 | 0.020 |
Why?
|
| Heart | 1 | 1990 | 850 | 0.020 |
Why?
|
| Technetium | 2 | 1975 | 38 | 0.020 |
Why?
|
| Social Control, Formal | 2 | 1976 | 12 | 0.010 |
Why?
|
| Constriction | 1 | 1984 | 37 | 0.010 |
Why?
|
| Disease Management | 1 | 2006 | 248 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 24 | 0.010 |
Why?
|
| Abscess | 1 | 1984 | 37 | 0.010 |
Why?
|
| Myocardium | 1 | 1990 | 1204 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1983 | 89 | 0.010 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1983 | 17 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1983 | 63 | 0.010 |
Why?
|
| Sutures | 1 | 1983 | 32 | 0.010 |
Why?
|
| Exercise Test | 1 | 1984 | 242 | 0.010 |
Why?
|
| Oxygen | 2 | 1987 | 386 | 0.010 |
Why?
|
| Neomycin | 1 | 1983 | 56 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1982 | 12 | 0.010 |
Why?
|
| Achievement | 1 | 1982 | 22 | 0.010 |
Why?
|
| Survival Rate | 2 | 1996 | 1056 | 0.010 |
Why?
|
| Ethical Review | 1 | 2002 | 2 | 0.010 |
Why?
|
| Contract Services | 1 | 2002 | 6 | 0.010 |
Why?
|
| Researcher-Subject Relations | 1 | 2002 | 4 | 0.010 |
Why?
|
| Financial Support | 1 | 2002 | 5 | 0.010 |
Why?
|
| Heart Valves | 2 | 1980 | 171 | 0.010 |
Why?
|
| Jurisprudence | 1 | 1981 | 11 | 0.010 |
Why?
|
| Biotechnology | 1 | 2002 | 34 | 0.010 |
Why?
|
| Paragonimiasis | 1 | 1981 | 1 | 0.010 |
Why?
|
| Empyema | 1 | 1981 | 6 | 0.010 |
Why?
|
| Venous Pressure | 1 | 1981 | 7 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1981 | 21 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1982 | 91 | 0.010 |
Why?
|
| Heparin | 1 | 1982 | 205 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 2 | 1986 | 85 | 0.010 |
Why?
|
| Prostaglandins E, Synthetic | 1 | 1980 | 5 | 0.010 |
Why?
|
| Lung Compliance | 1 | 1980 | 10 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1980 | 35 | 0.010 |
Why?
|
| Digitalis | 1 | 2000 | 5 | 0.010 |
Why?
|
| Dogs | 1 | 1981 | 490 | 0.010 |
Why?
|
| Magnesium Deficiency | 1 | 2000 | 6 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1980 | 96 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2000 | 34 | 0.010 |
Why?
|
| Plants, Toxic | 1 | 2000 | 33 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1980 | 107 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1980 | 94 | 0.010 |
Why?
|
| Xenon Radioisotopes | 2 | 1977 | 6 | 0.010 |
Why?
|
| State Medicine | 1 | 1979 | 7 | 0.010 |
Why?
|
| Plants, Medicinal | 1 | 2000 | 43 | 0.010 |
Why?
|
| Phytotherapy | 1 | 2000 | 53 | 0.010 |
Why?
|
| Thermodilution | 1 | 1979 | 20 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1981 | 618 | 0.010 |
Why?
|
| Creatinine | 1 | 1980 | 243 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 168 | 0.010 |
Why?
|
| Computers | 1 | 1979 | 63 | 0.010 |
Why?
|
| Endothelium | 1 | 1979 | 98 | 0.010 |
Why?
|
| Ampicillin | 2 | 1976 | 17 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 334 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1979 | 123 | 0.010 |
Why?
|
| Cause of Death | 1 | 1999 | 241 | 0.010 |
Why?
|
| Triamcinolone | 1 | 1978 | 11 | 0.010 |
Why?
|
| Models, Biological | 1 | 1981 | 981 | 0.010 |
Why?
|
| Pulmonary Heart Disease | 1 | 1976 | 3 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1976 | 7 | 0.010 |
Why?
|
| Oxacillin | 1 | 1976 | 4 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1977 | 172 | 0.010 |
Why?
|
| Pericarditis, Constrictive | 1 | 1976 | 4 | 0.010 |
Why?
|
| Erythromycin | 1 | 1976 | 13 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2000 | 1738 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 929 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1975 | 25 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1976 | 136 | 0.010 |
Why?
|
| Preoperative Care | 2 | 1987 | 275 | 0.010 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1975 | 25 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1995 | 34 | 0.010 |
Why?
|
| Azygos Vein | 1 | 1974 | 2 | 0.010 |
Why?
|
| Bronchography | 1 | 1974 | 5 | 0.010 |
Why?
|
| Bronchial Fistula | 1 | 1974 | 5 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1975 | 42 | 0.010 |
Why?
|
| Diaphragm | 1 | 1974 | 22 | 0.010 |
Why?
|
| Heart Aneurysm | 1 | 1974 | 21 | 0.010 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1974 | 20 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 168 | 0.010 |
Why?
|
| Intestinal Fistula | 1 | 1974 | 26 | 0.010 |
Why?
|
| Hemoptysis | 1 | 1974 | 28 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1994 | 20 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1994 | 24 | 0.010 |
Why?
|
| Government | 1 | 1974 | 2 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1996 | 185 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1994 | 242 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1994 | 236 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1994 | 98 | 0.010 |
Why?
|
| Bundle of His | 1 | 1992 | 21 | 0.010 |
Why?
|
| Mortality | 1 | 1993 | 163 | 0.010 |
Why?
|
| Atrioventricular Node | 1 | 1992 | 39 | 0.010 |
Why?
|
| Cryosurgery | 1 | 1992 | 53 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1991 | 62 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 1994 | 229 | 0.010 |
Why?
|
| Critical Illness | 1 | 1993 | 191 | 0.010 |
Why?
|
| Health Expenditures | 1 | 1974 | 170 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1991 | 47 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1993 | 792 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1993 | 1046 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1990 | 313 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1991 | 1753 | 0.000 |
Why?
|
| Arteries | 1 | 1987 | 108 | 0.000 |
Why?
|
| Character | 1 | 1985 | 1 | 0.000 |
Why?
|
| Intelligence | 1 | 1985 | 45 | 0.000 |
Why?
|
| Arm | 1 | 1984 | 59 | 0.000 |
Why?
|
| Heart Murmurs | 1 | 1984 | 6 | 0.000 |
Why?
|
| Posture | 1 | 1984 | 107 | 0.000 |
Why?
|
| Education, Medical, Continuing | 1 | 1985 | 136 | 0.000 |
Why?
|
| Leg | 1 | 1984 | 191 | 0.000 |
Why?
|
| Heart Rate | 1 | 1984 | 568 | 0.000 |
Why?
|
| Empyema, Tuberculous | 1 | 1981 | 1 | 0.000 |
Why?
|
| Thoracoplasty | 1 | 1981 | 2 | 0.000 |
Why?
|
| Physical Therapy Modalities | 1 | 1982 | 133 | 0.000 |
Why?
|
| Thrombophlebitis | 1 | 1980 | 47 | 0.000 |
Why?
|
| Popliteal Artery | 1 | 1980 | 40 | 0.000 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1980 | 27 | 0.000 |
Why?
|
| Ductus Arteriosus | 1 | 1980 | 13 | 0.000 |
Why?
|
| Umbilical Arteries | 1 | 1980 | 9 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1980 | 139 | 0.000 |
Why?
|
| Spleen | 1 | 1980 | 301 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1980 | 279 | 0.000 |
Why?
|
| Angiography | 1 | 1977 | 194 | 0.000 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1975 | 2 | 0.000 |
Why?
|
| Cellulitis | 1 | 1975 | 13 | 0.000 |
Why?
|
| Antigens, Bacterial | 1 | 1975 | 54 | 0.000 |
Why?
|
| Pleural Effusion | 1 | 1975 | 74 | 0.000 |
Why?
|
| Polyethylene Terephthalates | 1 | 1974 | 29 | 0.000 |
Why?
|
| Hematocrit | 1 | 1974 | 70 | 0.000 |
Why?
|
| Respiratory Tract Infections | 1 | 1975 | 91 | 0.000 |
Why?
|
| Age Factors | 1 | 1979 | 1864 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1974 | 159 | 0.000 |
Why?
|
| Ischemia | 1 | 1974 | 229 | 0.000 |
Why?
|
| Body Weight | 1 | 1974 | 554 | 0.000 |
Why?
|
| Seizures | 1 | 1974 | 279 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1974 | 807 | 0.000 |
Why?
|